As a financial analyst, after reviewing the earnings call transcript, it is recommended to adopt an 'underweight' investment stance for Walgreens Boots Alliance based on the following key financial metrics:

1. Sales: Overall sales for the quarter were $30.1 billion, up 2.1% versus the comparable quarter. However, on a constant currency basis, sales were up 5%, indicating a potential impact of currency fluctuations on the company's revenue.

2. GAAP operating income: Despite an increase in sales, GAAP operating income decreased by 1%, suggesting potential challenges in controlling operational costs and maximizing profitability.

3. Adjusted net earnings: While adjusted net earnings were up 11.9% and in constant currency up 13.6%, this increase was primarily attributed to a lower tax rate and gains from disposals, which may not be sustainable in the long term.

4. Retail Pharmacy USA: Although sales for the division increased, adjusted gross profit was down 0.5%, indicating potential pressure on margins and profitability within the retail segment.

5. Retail Pharmacy International: Sales for the division were down 0.2% in constant currency, and adjusted operating income decreased by 14% in constant currency, highlighting potential challenges in international markets.

6. Pharmaceutical Wholesale: While sales for the division increased, the adjusted operating margin was down 0.1 percentage points, suggesting potential challenges in maintaining profitability within the wholesale segment.

In conclusion, the above financial metrics indicate potential challenges in controlling costs, maintaining margins, and sustaining earnings growth for Walgreens Boots Alliance. Therefore, it is recommended to adopt an 'underweight' investment stance until there are clear indications of sustained improvement in key financial metrics.